Target intelligence / Profile preview

ABRAXAS1 pseudogene 2 (ABRAXAS1P2)

Target: ABRAXAS1P2
Molecular classification: Other, Pseudogene

Overview

ABRAXAS1 pseudogene 2 (ABRAXAS1P2) designates a non-functional, non-coding DNA sequence similar to the ABRAXAS1 gene. Pseudogenes are typically non-transcribed and non-translated, and do not produce functional protein. Most scientific and clinical databases do not list ABRAXAS1P2 as a structured entity or therapeutic target—available data focuses on the canonical ABRAXAS1 gene, which is involved in DNA damage response and hereditary cancer syndromes[1][2][4]. ABRAXAS1P2 has no demonstrated role in molecular biology, disease, or pharmacology.

Beyond the preview

Go deeper on ABRAXAS1 pseudogene 2 (ABRAXAS1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABRAXAS1 pseudogene 2 (ABRAXAS1P2).

Explore the full profile